KDIGO 2026 guideline on anaemia in CKD, updating the 2012 version: covers diagnosis and evaluation, iron, erythropoiesis-stimulating agents, HIF-prolyl hydroxylase inhibitors and red cell transfusion, with GRADE-rated recommendations developed with patient partners.
Guideline
Babitt et al. Executive Summary of the KDIGO 2026 Clinical Practice Guideline for the Management of Anemia in Chronic Kidney Disease (CKD)